Cargando…

A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma

BACKGROUND: Cell division cycle associated 2 (CDCA2), a member of the cell division cycle associated proteins (CDCA) family, is crucial in the regulation of cell mitosis and DNA repair. CDCA2 was extensively examined in our work to determine its role in a wide range of cancers. METHODS: CDCA2 differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenle, Lv, Dong, Yao, Jieqin, Chen, Boxian, Liu, Huanqiang, Li, Wensheng, Xu, Chengjie, Li, Zhenzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513342/
https://www.ncbi.nlm.nih.gov/pubmed/37733705
http://dx.doi.org/10.1371/journal.pone.0291024
_version_ 1785108548414341120
author Li, Wenle
Lv, Dong
Yao, Jieqin
Chen, Boxian
Liu, Huanqiang
Li, Wensheng
Xu, Chengjie
Li, Zhenzhe
author_facet Li, Wenle
Lv, Dong
Yao, Jieqin
Chen, Boxian
Liu, Huanqiang
Li, Wensheng
Xu, Chengjie
Li, Zhenzhe
author_sort Li, Wenle
collection PubMed
description BACKGROUND: Cell division cycle associated 2 (CDCA2), a member of the cell division cycle associated proteins (CDCA) family, is crucial in the regulation of cell mitosis and DNA repair. CDCA2 was extensively examined in our work to determine its role in a wide range of cancers. METHODS: CDCA2 differential expression was studied in pan-cancer and in diverse molecular and immunological subgroups in this research. Additionally, the diagnostic and prognostic significance of CDCA2 in pan-cancer was also evaluated using receiver operating characteristic (ROC) and Kaplan–Meier (KM) curves. Prognostic value of CDCA2 in distinct clinical subgroups of lower grade glioma (LGG) was also investigated and a nomogram was constructed. Lastly, potential mechanisms of action of CDCA2 were interrogated including biological functions, ceRNA networks, m6A modification and immune infiltration. RESULTS: CDCA2 is shown to be differentially expressed in a wide variety of cancers. Tumors are diagnosed and forecasted with a high degree of accuracy by CDCA2, and the quantity of expression CDCA2 is linked to the prognosis of many cancers. Additionally, the expression level of CDCA2 in various subgroups of LGG is also closely related to prognosis. The results of enrichment analyses reveal that CDCA2 is predominantly enriched in the cell cycle, mitosis, and DNA replication. Subsequently, hsa-miR-105-5p is predicted to target CDCA2. In addition, 4 lncRNAs were identified that may inhibit the hsa-miR-105-5p/CDCA2 axis in LGG. Meanwhile, CDCA2 expression is shown to be associated to m6A-related genes and levels of immune cell infiltration in LGG. CONCLUSION: CDCA2 can serve as a novel biomarker for the diagnosis and prognosis in pan-cancer, especially in LGG. For the development of novel targeted therapies in LGG, it may be a potential molecular target. However, to be sure, we’ll need to do additional biological experiments to back up our results from bioinformatic predictions.
format Online
Article
Text
id pubmed-10513342
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-105133422023-09-22 A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma Li, Wenle Lv, Dong Yao, Jieqin Chen, Boxian Liu, Huanqiang Li, Wensheng Xu, Chengjie Li, Zhenzhe PLoS One Research Article BACKGROUND: Cell division cycle associated 2 (CDCA2), a member of the cell division cycle associated proteins (CDCA) family, is crucial in the regulation of cell mitosis and DNA repair. CDCA2 was extensively examined in our work to determine its role in a wide range of cancers. METHODS: CDCA2 differential expression was studied in pan-cancer and in diverse molecular and immunological subgroups in this research. Additionally, the diagnostic and prognostic significance of CDCA2 in pan-cancer was also evaluated using receiver operating characteristic (ROC) and Kaplan–Meier (KM) curves. Prognostic value of CDCA2 in distinct clinical subgroups of lower grade glioma (LGG) was also investigated and a nomogram was constructed. Lastly, potential mechanisms of action of CDCA2 were interrogated including biological functions, ceRNA networks, m6A modification and immune infiltration. RESULTS: CDCA2 is shown to be differentially expressed in a wide variety of cancers. Tumors are diagnosed and forecasted with a high degree of accuracy by CDCA2, and the quantity of expression CDCA2 is linked to the prognosis of many cancers. Additionally, the expression level of CDCA2 in various subgroups of LGG is also closely related to prognosis. The results of enrichment analyses reveal that CDCA2 is predominantly enriched in the cell cycle, mitosis, and DNA replication. Subsequently, hsa-miR-105-5p is predicted to target CDCA2. In addition, 4 lncRNAs were identified that may inhibit the hsa-miR-105-5p/CDCA2 axis in LGG. Meanwhile, CDCA2 expression is shown to be associated to m6A-related genes and levels of immune cell infiltration in LGG. CONCLUSION: CDCA2 can serve as a novel biomarker for the diagnosis and prognosis in pan-cancer, especially in LGG. For the development of novel targeted therapies in LGG, it may be a potential molecular target. However, to be sure, we’ll need to do additional biological experiments to back up our results from bioinformatic predictions. Public Library of Science 2023-09-21 /pmc/articles/PMC10513342/ /pubmed/37733705 http://dx.doi.org/10.1371/journal.pone.0291024 Text en © 2023 Li et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Li, Wenle
Lv, Dong
Yao, Jieqin
Chen, Boxian
Liu, Huanqiang
Li, Wensheng
Xu, Chengjie
Li, Zhenzhe
A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
title A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
title_full A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
title_fullStr A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
title_full_unstemmed A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
title_short A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
title_sort pan-cancer analysis reveals the diagnostic and prognostic role of cdca2 in low-grade glioma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513342/
https://www.ncbi.nlm.nih.gov/pubmed/37733705
http://dx.doi.org/10.1371/journal.pone.0291024
work_keys_str_mv AT liwenle apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT lvdong apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT yaojieqin apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT chenboxian apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT liuhuanqiang apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT liwensheng apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT xuchengjie apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT lizhenzhe apancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT liwenle pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT lvdong pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT yaojieqin pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT chenboxian pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT liuhuanqiang pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT liwensheng pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT xuchengjie pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma
AT lizhenzhe pancanceranalysisrevealsthediagnosticandprognosticroleofcdca2inlowgradeglioma